Tectonic Therapeutic, Inc. 4

CEO Alise Reicin received an employee stock option award for 69,250 shares of Tectonic Therapeutic, Inc. common stock at a $29.92 exercise price.

On September 3, 2026, Chief Executive Officer Alise Reicin received an employee stock option grant from Tectonic Therapeutic, Inc. for 69,250 shares of common stock at an exercise price of $29.92 per share, with no shares immediately vested. The option is scheduled to vest as to 1/8 of the underlying shares on September 3, 2026, and the remaining shares in 42 equal monthly installments beginning October 3, 2026, contingent on continued service. This award represents a long-dated equity incentive (expiring September 2, 2036) and is characteristic of routine executive compensation, with no concurrent open-market purchases or sales reported.

Filing Facts

CIK

1681087

Ticker

TECX

Form

4

Source Type

fda

Accession

0001757533-26-000014

Alert Tier

5